Updated May 11, 2001

28th Scandinavian Congress of Rheumatology
September 7-10, 2000
Turku, Finland



SIMILAR EFFECT ON X-RAY PROGRESSION IN EARLY RA-PATIENTS WITH REUMACON OR METHOTREXATE.
View

Annual European Congress of Rheumatology
June 21 - 24, 2000
Nice, France


SIMILAR EFFECT ON X-RAY PROGRESSION IN EARLY RA-PATIENTS WITH REUMACON OR METHOTREXATE.
View

XIV European League Against Rheumatism Congress
June 6 - 11, 1999
Glasgow, Scotland


REUMACON (CPH 82) IN REFACTORY INFLAMMATORY ARTHRITIS.
View

STUDY OF CPH 82 VS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS.
View

CPH 82 VERSUS AZATHIOPRINE IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND REACTIVE (AA) AMYLOIDOSIS.
View


ACR 62nd National Meeting,
November 8 - 12, 1998
San Diego, United States


A CLINICAL STUDY OF CPH 82 VS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS.
View

28 Tagung der Deutschen
Gesellschaft für Rheumatologie"
September 16 - 19, 1998
Baden-Baden, Germany


A RETROSPECTIVE STUDY ON THE SAFETY OF CPH 82/-REUMACON® IN THE LONG TERM TREATMENT OF RHEUMATOID ARTHRITIS
View

CLINICAL OPEN STUDY OF A PODOPHYLLOTOXIN DERIVATIVE (CPH 82) VERSUS AZATHIOPRINE (AZA) IN TREATMENT OF RHEUMATOID ARTHRITIS AND REACTIVE (AA) AMYLOIDOSIS.
View






CPH 82 DEMONSTRATED TO BE A SAFE DRUG IN FOUR LONG-TERM STUDIES IN PATIENTS WITH RHEUMATOID ARTHRITIS